UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center

Leukemia, 2015-02, Vol.29 (2), p.312-320

2015

Volltextzugriff (PDF)

Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia

Leukemia, 2016-03, Vol.30 (3), p.708-715

2016

Volltextzugriff (PDF)

Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study

The Lancet (British edition), 2002-11, Vol.360 (9343), p.1361-1368

2002

Volltextzugriff (PDF)

Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012

Leukemia, 2016-01, Vol.30 (1), p.24-31

2016

Volltextzugriff (PDF)

Nilotinib in patients with Ph + chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results

Leukemia, 2012-06, Vol.26 (6), p.1189-1194

2012

Volltextzugriff (PDF)

Aberrant marker expression patterns on the CD34+CD38− stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission

Leukemia, 2007-08, Vol.21 (8), p.1700-1707

2007

Volltextzugriff (PDF)

Improved risk stratification by the integration of the revised International Prognostic Scoring System with the Myelodysplastic Syndromes Comorbidity Index

European journal of cancer (1990), 2014-12, Vol.50 (18), p.3198-3205

2014

Volltextzugriff (PDF)

Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial

Haematologica (Roma), 2013-02, Vol.98 (2), p.172-178

2013

Volltextzugriff (PDF)

Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40

Leukemia, 2011-11, Vol.25 (11), p.1697-1703

2011

Volltextzugriff (PDF)

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

Leukemia, 2020-10, Vol.34 (10), p.2820-2820

2020

Volltextzugriff (PDF)

Measurable residual disease testing in acute myeloid leukaemia

Leukemia, 2017-07, Vol.31 (7), p.1482-1490

2017

Volltextzugriff (PDF)

MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia

Leukemia, 2004-08, Vol.18 (8), p.1380-1390

2004

Volltextzugriff (PDF)

The war on clones: a Darwinian enigma

Blood, 2021-06, Vol.137 (22), p.3008-3009

2021

Volltextzugriff (PDF)

Immunohistochemical profiling based on Bcl-2, CD10 and MUMI expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma

The Journal of pathology, 2006-04, Vol.208 (5), p.714-723

2006

Volltextzugriff (PDF)

Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy

Bone marrow transplantation (Basingstoke), 2011-06, Vol.46 (6), p.840-846

2011

Volltextzugriff (PDF)

Residual normal stem cells can be detected in newly diagnosed chronic myeloid leukemia patients by a new flow cytometric approach and predict for optimal response to imatinib

Leukemia, 2012-05, Vol.26 (5), p.977-984

2012

Volltextzugriff (PDF)

Acute leukemias of ambiguous lineage: diagnostic consequences of the WHO2008 classification

Leukemia, 2010-07, Vol.24 (7), p.1392-1396

2010

Volltextzugriff (PDF)

Response to letter commenting on: Prognostic relevance of morphological classification models for myelodysplastic syndromes in an era of the revised International Prognostic Scoring System

European journal of cancer (1990), 2017-02, Vol.72, p.269-271

2017

Volltextzugriff (PDF)

A simple one-tube assay for immunophenotypical quantification of leukemic stem cells in acute myeloid leukemia

Leukemia, 2016-02, Vol.30 (2), p.439-446

2016

Volltextzugriff (PDF)

Evaluating ivosidenib for the treatment of acute myeloid leukemia

Expert opinion on pharmacotherapy, 2020-12, Vol.21 (18), p.2205-2213

2020

Volltextzugriff (PDF)

Allogeneic transplantation after reduced-intensity conditioning with fludarabine-CY for both indolent and aggressive lymphoid malignancies

Bone marrow transplantation (Basingstoke), 2014-04, Vol.49 (4), p.513-518

2014

Volltextzugriff (PDF)

Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortality

Leukemia, 2019-06, Vol.33 (6), p.1349-1359

2019

Volltextzugriff (PDF)

ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified

Histopathology, 2003-11, Vol.43 (5), p.462-469

2003

Volltextzugriff (PDF)

Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy

Annals of oncology, 1998-07, Vol.9 (7), p.739-744

1998

Volltextzugriff (PDF)

1 – 25 von 470

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(435)
Mit Volltextzugriff
(392)

Publikationsform

Sprache

Englisch
(459)
Niederländisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(338)
Life Sciences & Biomedicine
(333)
Humans
(325)
Hematology
(186)
Male
(185)
Middle Aged
(183)
Female
(178)
Biological And Medical Sciences
(174)
Medical Sciences
(169)
Adult
(161)
Oncology
(151)
Aged
(132)
Hematologic And Hematopoietic Diseases
(104)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(102)
Adolescent
(82)
Leukemia
(75)
Prognosis
(66)
Treatment Outcome
(62)
Acute Myeloid Leukemia
(54)
Pharmacology. Drug Treatments
(49)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Leukemia
(66)
Blood
(64)
Haematologica
(24)
Journal Of Clinical Oncology
(17)
Bone Marrow Transplantation
(15)
Alzheimer's & Dementia
(14)
European Journal Of Haematology
(11)
Leukemia Research
(10)
Nederlands Tijdschrift Voor Geneeskunde
(10)
Netherlands Journal Of Medicine
(10)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center

Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia

Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study

Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012

Nilotinib in patients with Ph + chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results

Aberrant marker expression patterns on the CD34+CD38− stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission

Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome

Improved risk stratification by the integration of the revised International Prognostic Scoring System with the Myelodysplastic Syndromes Comorbidity Index

Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial

Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

Measurable residual disease testing in acute myeloid leukaemia

MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia

The war on clones: a Darwinian enigma

Immunohistochemical profiling based on Bcl-2, CD10 and MUMI expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma

Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy

Residual normal stem cells can be detected in newly diagnosed chronic myeloid leukemia patients by a new flow cytometric approach and predict for optimal response to imatinib

Acute leukemias of ambiguous lineage: diagnostic consequences of the WHO2008 classification

Response to letter commenting on: Prognostic relevance of morphological classification models for myelodysplastic syndromes in an era of the revised International Prognostic Scoring System

A simple one-tube assay for immunophenotypical quantification of leukemic stem cells in acute myeloid leukemia

Evaluating ivosidenib for the treatment of acute myeloid leukemia

Allogeneic transplantation after reduced-intensity conditioning with fludarabine-CY for both indolent and aggressive lymphoid malignancies

Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortality

ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified

Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy

Suchergebnisse filtern